ElevenLabs

ElevenLabs Raises $80M Series B

AI voice technology company creating realistic text-to-speech and voice cloning tools for content creators and developers

Key Highlights

• Funding Amount: $80M Series B
• Valuation: $1.1B
• Headquarters: New York, NY
• Founded: 2022
• Employees: 40-80
• Total Raised: $101M

About the Funding Round

ElevenLabs has successfully closed $80M Series B in funding, marking a significant milestone in the company's growth trajectory. This investment will enable the company to accelerate product development, expand market reach, and strengthen its position in the ai/ml sector.

Investor Syndicate

The round was backed by a prestigious group of investors:

• Andreessen Horowitz
• Nat Friedman
• Daniel Gross

This diverse group of investors brings not only capital but also strategic expertise and valuable networks that will help ElevenLabs achieve its ambitious goals.

Market Opportunity

The ai/ml market continues to experience rapid growth, driven by increasing demand for innovative solutions and digital transformation across industries. ElevenLabs's unique approach and proven technology position it well to capture significant market share in the coming years.

Company Background

Founded in 2022 and headquartered in New York, NY, ElevenLabs has established itself as an innovative player in the ai/ml space. With 40-80 employees, the company has built a strong team focused on delivering exceptional value to customers.

Next Steps

With this new funding, ElevenLabs plans to:

• Accelerate product development and innovation
• Expand into new markets and geographies
• Grow the team across engineering, sales, and operations
• Strengthen partnerships with key industry players
• Scale infrastructure to support rapid growth

Industry Impact

This funding round represents a strong vote of confidence in ElevenLabs's vision and execution. The investment will help drive innovation in the ai/ml sector and create new opportunities for customers and partners.

For more information about ElevenLabs, visit their website or contact their press office.